selected scholarly activity
-
conferences
- Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study. Value in Health. A338-A338. 2015
- The Processes For A Common Quality Assurance Approach To Multi-Centre Clinical Trials – The Mars Excite Experience. Value in Health. A36-A36. 2015
- Evaluation Of A Chronic Disease Management System For The Treatment And Management Of Diabetes In Primary Health Care Practices In Ontario. Value in Health. A144-A144. 2014
- Prehospital Evaluation and Economic Analysis of DIfferent Coronary Syndrome Treatment Strategies (PREDICT)-A Prospective Cohort Study. Circulation. 2013
- How can we use discrete event simulation to improve access to health care: an assessment of increasing access to care for children with medically refractory epilepsy. Value in Health. A108-A109. 2013
- Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems. Value in Health. A288-A288. 2013
- PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis. Value in Health. A325-A325. 2012
- PMD8 Efficacy of Systemic Hyperbaric Oxygen Therapy for Non-Healing Diabetic Ulcers of the Lower Limb: Systematic Review and Meta-Analysis. Value in Health. A63-A63. 2012
- 2015 CHANGES IN ERECTILE FUNCTION AFTER PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA. Investigative Urology. E813-E814. 2012
- PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Value in Health. A75-A75. 2011
- HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO. Value in Health. A133-A133. 2010
- PSY18 THE BURDEN OF OBESITY IN ONTARIO. Value in Health. A378-A378. 2009
- PSY9 USING UTILIZATION RECORDS TO ESTIMATE THE BURDEN OF OBESITY IN ADULTS LIVING IN ONTARIO. Value in Health. A131-A131. 2009
- PHP74 THE CADTH GUIDELINES FORTHE ECONOMIC EVALUATION OF HEALTH TECHNOLOGIES: DO CURRENT CANADIAN ECONOMIC EVALUATIONS PASS THE TEST?. Value in Health. A51-A51. 2008
- Drug eluting stent among diabetics: A propensity analysis of a large population-based cohort. Journal of the American College of Cardiology. A247-A247. 2008
- PCV77 DISCRETE-EVENT-SIMULATION AN APPROACH THAT CHALLENGES TRADITIONAL MODELING METHODS? AN ILLUSTRATION USING DRUG-ELUTING STENTS. Value in Health. A361-A361. 2006
- CE4 COST EFFECTIVENESS OF DRUG ELUTING STENTS (DES) COMPARED TO BARE METAL STENTS (BMS) USING “REAL WORLD” DATA. Value in Health. A8-A8. 2006
- PSU1 COST-UTILTY OF ELECTIVE ENDOVASCULAR REPAIR (EVAR) COMPARED TO OPEN SURGICAL REPAIR (OSR) OF ABDOMINAL AORTIC ANEURYSMS (AAA). Value in Health. A173-A173. 2006
- THEOPHYLLINE BIOTRANSFORMATION TO A NEW, RIBOSYLATED METABOLITE. Clinical Pharmacology and Therapeutics. 148-148. 1993
- THEOPHYLLINE (THEO) BIOTRANSFORMATION BY HUMAN LUNG MICROSOMES. Clinical Pharmacology and Therapeutics. 178-178. 1992
-
journal articles
- Describing the state of a research network: A mixed methods approach to network evaluation. Research Evaluation. 32:188-199. 2023
- To save the vision of persons with diabetes Canada needs data-informed timely screening. Canadian Journal of Ophthalmology. 58:e228-e229. 2023
- Inter-individual relationships within a Canadian SPOR research network: a social network study. BMC Health Services Research. 22:955. 2022
- Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial. Translational Psychiatry. 12:214. 2022
- Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial. Translational Psychiatry. 12:101. 2022
- Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial. Canadian Journal of Diabetes. 46:165-170. 2022
- A Mixed-Methods Evaluation of Diabetic Retinopathy Screening Supported by Provincial Health-Care Administrative Data. Canadian Journal of Diabetes. 45:S31-S31. 2021
- Access and Analysis of Provincial Healthcare Administrative Data for Cohort Disclosure to Guide Community-Based Diabetic Retinopathy Screening. Canadian Journal of Diabetes. 45:S32-S32. 2021
- Increasing Diabetic Retinopathy Screening Rates Utilizing Provincial Health-Care Administrative Data. Canadian Journal of Diabetes. 45:S31-S31. 2021
- Angular analysis of the decay B+ → K∗(892)+μ+μ− in proton-proton collisions at $$ \sqrt{\mathrm{s}} $$ = 8 TeV. Journal of High Energy Physics (JHEP). 2021. 2021
- Evidence-Based Decision Making 3: Health Technology Assessment. Methods in molecular biology (Clifton, N.J.). 2249:429-454. 2021
- GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making. Journal of Clinical Epidemiology. 129:138-150. 2021
- Multicentre, single-blind randomised controlled trial comparing MyndMove neuromodulation therapy with conventional therapy in traumatic spinal cord injury: a protocol study. BMJ Open. 10:e039650-e039650. 2020
-
Probing the chiral magnetic wave in
- Search for the production of four top quarks in the single-lepton and opposite-sign dilepton final states in proton-proton collisions at $$ \sqrt{s} $$ = 13 TeV. Journal of High Energy Physics (JHEP). 2019. 2019
- 42 - A Multicentre, Prospective, Observational Study of Diabetes Self-Management and Behavioural Change in Newly Referred Patients to Diabetes Education Centres. Canadian Journal of Diabetes. 43:S19-S19. 2019
- Search for supersymmetry with a compressed mass spectrum in the vector boson fusion topology with 1-lepton and 0-lepton final states in proton-proton collisions at $$ \sqrt{s} $$ = 13 TeV. Journal of High Energy Physics (JHEP). 2019. 2019
-
Measurement and interpretation of differential cross sections for Higgs boson production at
- Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades. Journal of Psychiatry & Neuroscience. 44:151-163. 2019
-
Search for
- Search for a heavy resonance decaying to a top quark and a vector-like top quark in the lepton + jets final state in pp collisions at $$\sqrt{s} = 13\,\text {TeV} $$ s = 13 TeV. European Physical Journal C. 79. 2019
- Measurement of inclusive and differential Higgs boson production cross sections in the diphoton decay channel in proton-proton collisions at $$ \sqrt{s}=13 $$ TeV. Journal of High Energy Physics (JHEP). 2019. 2019
- Search for disappearing tracks as a signature of new long-lived particles in proton-proton collisions at $$ \sqrt{s}=13 $$ TeV. Journal of High Energy Physics (JHEP). 2018. 2018
- Measurement of b hadron lifetimes in pp collisions at $$\sqrt{s} = 8$$ s = 8 $$\,\text {Te}\text {V}$$ TeV. European Physical Journal C. 78:457. 2018
- Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada. ClinicoEconomics and Outcomes Research. Volume 10:201-212. 2018
- Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada. ClinicoEconomics and Outcomes Research. Volume 10:655-663. 2018
- Constraints on anomalous Higgs boson couplings using production and decay information in the four-lepton final state. Physics Letters B. 775:1-24. 2017
- Feasibility of an altruistic sperm donation program in Canada: results from a population-based model. Reproductive Health. 14:8. 2017
- Search for supersymmetry in events with at least one photon, missing transverse momentum, and large transverse event activity in proton-proton collisions at s = 13 $$ \sqrt{s}=13 $$ TeV. Journal of High Energy Physics (JHEP). 2017. 2017
- Examining a new functional electrical stimulation therapy with people with severe upper extremity hemiparesis and chronic stroke: A feasibility study. British Journal of Occupational Therapy. 80:651-659. 2017
- Relationship between hyperbaric oxygen therapy and quality of life in participants with chronic diabetic foot ulcers: data from a randomized controlled trial. Acta Diabetologica. 54:823-831. 2017
- Theophylline-7β-d-Ribofuranoside (Theonosine), a New Theophylline Metabolite Generated in Human and Animal Lung Tissue. Pharmaceutics. 9:28-28. 2017
- What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review. Journal of Population Therapeutics and Clinical Pharmacology. 24:e1-e20. 2017
- Measurements of differential production cross sections for a Z boson in association with jets in pp collisions at s = 8 $$ \sqrt{s}=8 $$ TeV. Journal of High Energy Physics (JHEP). 2017. 2017
- Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data. MDM Policy and Practice. 2:238146831769771-238146831769771. 2017
- Preliminary Results of the Adoption and Application of the Integrated Comprehensive Care Bundle Care Program When Treating Patients with Chronic Obstructive Pulmonary Disease. Canadian Respiratory Journal. 2017:1-10. 2017
- Process mapping evaluation of medication reconciliation in academic teaching hospitals: a critical step in quality improvement. BMJ Open. 6:e013663-e013663. 2016
- Response to Comments on Fedorko et al. Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Care 2016;39:392–399. Diabetes Reviews. 39:e136-e137. 2016
- Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Reviews. 39:392-399. 2016
- Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network. Hospital Pharmacist. 69:187-193. 2016
- The Integrated Comprehensive Care Program: A Novel Home Care Initiative After Major Thoracic Surgery. Seminars in Thoracic and Cardiovascular Surgery. 28:574-582. 2016
- Evidence-Based Decision-Making 3: Health Technology Assessment. Methods in molecular biology (Clifton, N.J.). 1281:417-441. 2015
- Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey.. Ontario Health Technology Assessment Series. 15:1-67. 2015
- Systematic Review and Meta-analysis of the Benefits of Out-of-Hospital 12-Lead ECG and Advance Notification in ST-Segment Elevation Myocardial Infarction Patients. Annals of Emergency Medicine. 64:176-186.e9. 2014
- Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study.. Ontario Health Technology Assessment Series. 14:1-37. 2014
- Access to surgery for paediatric patients with medically refractory epilepsy: A systems analysis. Journal of Epilepsy. 107:286-296. 2013
- Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario. Expert Review of Pharmacoeconomics and Outcomes Research. 13:675-690. 2013
- HYPERBARIC OXYGEN THERAPY FOR DIABETIC ULCERS: SYSTEMATIC REVIEW AND META-ANALYSIS. International Journal of Technology Assessment in Health Care. 29:269-281. 2013
- A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Journal of the Canadian Urological Association. 7:335-335. 2013
- Electrical stimulation for drug-resistant epilepsy: An evidence-based analysis. Ontario Health Technology Assessment Series. 13. 2013
- Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.. Ontario Health Technology Assessment Series. 13:1-37. 2013
- Photoselective vaporization for the treatment of benign prostatic hyperplasia.. Ontario Health Technology Assessment Series. 13:1-34. 2013
- Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada. Value in Health. 15:894-906. 2012
- MATHEMATICAL MODELING: THE CASE OF EMERGENCY DEPARTMENT WAITING TIMES. International Journal of Technology Assessment in Health Care. 28:93-109. 2012
- The excess burden of osteoarthritis in the province of Ontario, Canada. Arthritis and Rheumatism. 64:1153-1161. 2012
- Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery.. Ontario Health Technology Assessment Series. 12:1-41. 2012
- A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. Trials. 12:69. 2011
- Prehospital evaluation and economic analysis of different coronary syndrome treatment strategies - PREDICT - Rationale, Development and Implementation. BMC Emergency Medicine. 11:4. 2011
- Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Review of Pharmacoeconomics and Outcomes Research. 11:513-521. 2011
- Using the Appropriate Fishing Net for Computed Tomographic Coronary Angiography in Daily Clinical Practice. JAMA Internal Medicine. 171:1512-1512. 2011
- Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Quality of Life Research. 20:939-943. 2011
- Ontario Multidetector Computed Tomographic Coronary Angiography Study. JAMA Internal Medicine. 171:1021-1029. 2011
- Should Endovascular Repair Be Reimbursed for Low Risk Abdominal Aortic Aneurysm Patients? Evidence from Ontario, Canada. International Journal of Vascular Medicine. 2011:1-10. 2011
- Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario. Value in Health. 13:S8-S11. 2010
- PMS58 HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO. Value in Health. 13:A133-A133. 2010
- A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment. PharmacoEconomics (Auckland). 28:255-277. 2010
- Impact of the 1997 Canadian Guidelines on the Conduct of Canadian-Based Economic Evaluations in the Published Literature. Value in Health. 13:328-334. 2010
- A review of the cost of cardiovascular disease. Canadian Journal of Cardiology. 25:e195-e202. 2009
- Conditionally Funded Field Evaluations and Practical Trial Design Within a Health Technology Assessment Framework. Journal of the American College of Radiology. 6:324-331. 2009
- Health Technology Assessment and Primary Data Collection for Reducing Uncertainty in Decision Making. Journal of the American College of Radiology. 6:332-342. 2009
- Illustrating Economic Evaluation of Diagnostic Technologies: Comparing Helicobacter pylori Screening Strategies in Prevention of Gastric Cancer in Canada. Journal of the American College of Radiology. 6:317-323. 2009
- Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura. Clinical Therapeutics. 31:1082-1091. 2009
- Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario. International Journal of Technology Assessment in Health Care. 25:196-207. 2009
- In search of the evidentiary foundation of published Canadian economic evaluations (2001–06). International Journal of Technology Assessment in Health Care. 25:214-221. 2009
- A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada. Value in Health. 12:245-252. 2009
- Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. European Heart Journal. 30:152-161. 2009
- Meeting report ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention. 4:427-436. 2009
- Reply. Journal of Vascular Surgery. 49:277-278. 2009
- Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. Journal of Vascular Surgery. 48:779-787. 2008
- Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand?. International Journal of Technology Assessment in Health Care. 24:437-444. 2008
- Safety and effectiveness of drug-eluting stents among diabetic patients: A propensity analysis. American Heart Journal. 156:125-134. 2008
- Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness Analysis. Journal of Studies on Alcohol and Drugs. 69:510-519. 2008
- Cost-effectiveness of reducing wait times for cataract surgery in Ontario. Canadian Journal of Ophthalmology. 43:213-217. 2008
- Effects of study design and trends for EVAR versus OSR. Vascular Health and Risk Management. Volume 4:1011-1022. 2008
- Effectiveness and Safety of Drug-Eluting Stents in Ontario. New England Journal of Medicine. 357:1393-1402. 2007
- Managing multiple projects: a literature review of setting priorities and a pilot survey of healthcare researchers in an academic setting.. Perspectives in health information management / AHIMA, American Health Information Management Association. 4:4. 2007
- Being Led Down the Wrong Garden PATH: the Importance of Knowledge and Facts for the Crossroads. PharmacoEconomics (Auckland). 25:528-532. 2007